BioAge Labs Inc (BIOA): Next-Year EPS Estimate 26.76%
As of 2026-07-31, BioAge Labs Inc (BIOA) has a next-year EPS growth estimate of 26.76%. Featured in 2 EPS revision reports, most recently on 2026-06-16.
On 2026-07-31, analyst consensus for BIOA's next-year EPS growth shifted from 26.79% to 26.76% — a negative change of 0.03 percentage points. Current-year growth is projected at -13.65%.
What's Driving This
The rise in BIOA stock appears primarily driven by an analyst upgrade on July 20, 2026, which raised the next‑year EPS growth estimate from 26.56% to 26.79%. No recent news headlines are available to link the move to any specific corporate catalyst such as an earnings beat, contract win, or guidance raise. The absence of additional public information makes the EPS revision the clearest structural factor behind the upward movement.
Generated 2026-07-28 from news as of 2026-07-28
Current Snapshot
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- EPS growth next year
- 26.76%
- EPS growth this year
- -13.65%
- EPS next quarter (est)
- -$0.61
- Last price
- $9.04
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-07-31 | 26.76% | -13.65% | -$0.61 | $9.04 |
| 2026-07-30 | 26.79% | -13.65% | -$0.61 | $24.85 |
| 2026-07-29 | 26.79% | -13.65% | -$0.61 | $22.19 |
| 2026-07-28 | 26.79% | -13.65% | -$0.61 | $21.92 |
| 2026-07-27 | 26.79% | -13.65% | -$0.61 | $20.88 |
| 2026-07-26 | 26.79% | -13.65% | -$0.61 | $21.77 |
| 2026-07-24 | 26.79% | -13.65% | -$0.61 | $21.77 |
| 2026-07-23 | 26.79% | -13.65% | -$0.61 | $21.90 |
| 2026-07-22 | 26.79% | -13.65% | -$0.61 | $21.94 |
| 2026-07-21 | 26.79% | -13.65% | -$0.61 | $22.65 |
| 2026-07-20 | 26.79% | -13.65% | -$0.61 | $22.32 |
| 2026-07-19 | 26.56% | -14.15% | -$0.61 | $22.81 |
| 2026-07-17 | 26.56% | -14.15% | -$0.61 | $22.81 |
| 2026-07-16 | 26.56% | -14.15% | -$0.61 | $22.16 |
| 2026-07-15 | 26.56% | -14.15% | -$0.61 | $22.70 |
| 2026-07-14 | 26.56% | -14.15% | -$0.61 | $22.78 |
| 2026-07-13 | 26.58% | -14.17% | -$0.61 | $21.78 |
| 2026-07-12 | 26.58% | -14.17% | -$0.61 | $24.34 |
| 2026-07-09 | 26.58% | -14.17% | -$0.61 | $24.89 |
| 2026-07-08 | 26.58% | -14.17% | -$0.61 | $23.63 |
| 2026-07-07 | 26.58% | -14.17% | -$0.61 | $24.40 |
| 2026-07-06 | 26.58% | -14.17% | -$0.61 | $24.84 |
| 2026-07-05 | 26.56% | -14.16% | -$0.61 | $25.10 |
| 2026-07-02 | 26.56% | -14.16% | -$0.61 | $25.10 |
| 2026-07-01 | 26.53% | -14.14% | -$0.61 | $24.26 |
| 2026-06-30 | 26.53% | -14.14% | -$0.61 | $24.51 |
| 2026-06-29 | 26.53% | -14.14% | -$0.61 | $24.95 |
| 2026-06-28 | 26.53% | -14.14% | -$0.61 | $23.76 |
| 2026-06-25 | 26.53% | -14.14% | -$0.61 | $22.62 |
| 2026-06-24 | 26.53% | -14.14% | -$0.61 | $22.83 |
Reports Featuring BIOA
Screen Performance
Aggregate stats across all 2015 tickers our top-EPS-revision screen has flagged over the past 147 days.
- Median return since detection
- +3.0%
- % of tickers in the green
- 56%
- Median return on winners
- +20.0%
- Large revisions captured
- 1609
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is BioAge Labs Inc's next-year EPS growth estimate?▾
As of 2026-07-31, BioAge Labs Inc (BIOA) has a next-year EPS growth estimate of 26.76%, based on analyst consensus.
When was the latest EPS estimate revision for BIOA?▾
The most recent revision occurred on 2026-07-31, when analysts adjusted the next-year EPS growth estimate from 26.79% to 26.76%.
What sector and industry does BioAge Labs Inc belong to?▾
BioAge Labs Inc operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. BIOA appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. BioAge Labs Inc (BIOA) appears here because it was detected by our daily top-EPS-revision-performer screen.